KILLED Corynebacterium parvum has powerful antitumour effects on many syngeneic animal tumours (Woodruff and Boak, 1966; Smith and Scott, 1972; Castro, 1974a) and it is now being assessed as an anticancer agent in man (Israel, 1975; Woodruff et al., 1975) . This vaccine has been shown in mice to be more effective against tumours if given i.v. or i.p. than if given s.c. (Woodruff and Inchley, 1971; Sadler and Castro, 1975 ).
C. parvum given i.v. stimulates the RES, as judged by clearance of colloidal carbon, and increases spleen and liver size (Halpern et al., 1964; Castro, 1974b) . It has adjuvant properties (Howard, Scott and C(hristie, 1973) but in defined circumstances appears to depress cell-mediated immianity (Scott, 1974a; Castro, 1974b) .
Little is known of the localization of C. parvum in vivo after injection. It was considered that such information might lead to a better understanding of the biological activity of this agent. Therefore, the aim of this study was to develop a method for radiolabelling C. parvum, to study the biological properties of this labelled vaccine, and to observe its distribution in normal and tumour-bearing mice.
MATERIALS AND METHODS C. parvum.-Freeze-dried live C. parvum (Wellcome, strain CN 6134) was used in the labelling studies. Formalin-killed C. parvum (Wellcome, strain CN 6134, batch PX 416, 7 mg dry weight/ml) was used as a control.
Radioactive labelling.-An inoculum of the freeze-dried C. parvum was added to a 20 ml suspension of Difco Bacto "cooked meat medium" containing 5% foetal calf serum (Gibco Biocult) and 1% glucose. After 7 days at 37°C in a tightly sealed universal bottle, the slurry of meat granules and bacteria was shaken, and 2 ml of the upper layer contain-ing mostly bacteria was added to 100 ml of Difco Bacto " antibiotic medium 3 " containing 1% glucose. After 7 days' growth without aeration, an 8-ml inoculum was taken from this culture and added to 11 fresh medium (antibiotic medium 3 plus 1% glucose). Deoxyadenosine 0-2 mg/ml (Sigma) was added (Boyce and Setlow, 1962) , followed by 1 juCi of [3H] thymidine (Radiochemical Centre, Amersham, sp. act. 59 Ci/mmol) after the deoxyadenosine had dissolved. The bacteria were harvested 5 days later, washed x 3 by centrifugation with 0.9% NaCl, and finally resuspended in normal saline containing 0.5% formalin for 7 days at 37°C. The killed cells were washed free of formalin and resuspended in normal saline containing 0-01% thiomersalate (BDH) as a preservative. The final suspension was concentrated at 7 mg dry weight/ml. The activity of 3 batches of labelled C. parvum prepared at different times was between 1 and 6 x 105 ct/min/0 1 ml.
A comparison of the activity of washed intact killed bacteria and that of the precipitate after disruption with cold 10% TCA showed that all the activity in the bacteria was in the form of high-mol.-wt. macromolecules. There was no loss of label from C. parvum during storage. Less than 0.25% of the activity present in the labelled bacteria was found in the supernatant when the vaccine was centrifuged 3 months after labelling. Microscopic examination of the killed labelled C. parvum indicated that there was no contamination by other bacteria, and both this radiolabelled C. parvurn and killed but unlabelled bacteria (prepared using similar techniques by Burroughs Wellcome) were morphologically similar.
Mice.-Age-matched adult female C57BL/ 10 Sc Sn mice obtained from Olac (Southern) Ltd were used. Tumour.-Lewis lung carcinoma was implanted s.c. as a 0-1 ml homogenate in the lower flank. It is an epidermoid tumour which originated spontaneously as a carcinoma of the lung of a female C57BL mouse at the Wistar Institute in 1951 (Sugiura and Stock, 1955 ). If grown s.c., it always metastasizes to the lungs (Simpson-Herren, Sanford and Holmquist, 1974) . For each animal, 2 diameters of the primary tumour were measured twice weekly and the mean diameter calculated. Macroscopic surface lung metastases were counted 21 days after tumour implantation, after staining the lungs by inflation with a dilute solution of Indian ink and fixation in Fekete's solution (Wexler, 1966) . The number of metastases in the different experimental groups was compared by Student's t test.
C. parvum injections.-C. parvum was given either i.v. as a dose of 0 44 mg diluted to 0-2 ml in normal saline, or i.p. or s.c. as 0'7 mg in 0 1 ml to untreated mice or to mice immediately after implantation of tumour.
Distribution studies.-Groups of 5 mice were anaesthetized with ether and exsanguinated from the retro-orbital sinus at 4 h and 1, 3, 7 and 14 days after injection of labelled C. parvum. Peritoneal cells were collected after injecting 3 ml of heparinized saline, i.p., and aspirating the cell-containing fluid after abdominal massage. The following tissues were removed for study: liver, spleen, mesenteric lymph nodes, small gut, kidney, thymus, lungs, heart, brain, skin, muscle and femoral bone marrow. In tumourbearing mice, the tumour and draining lymph nodes were also removed. Tissues were dissected free of connective tissue, rinsed in saline, blotted dry and weighed. In a separate experiment, bladder urine, faeces and gut contents were collected from groups of 3 mice. Whole organs, or samples of tissues up to 200 mg in weight, were added to scintillation vials containing 1 ml of the tissue solvent, ; when there was sufficient tissue, samples were studied in triplicate. 10 ml of scintillant (500 ml Triton x 100, 1 1 toluene and 6 g PPO) was added to the dissolved tissues, and the samples counted on an " Intertechnique " liquid scintillation spectrometer. An internal standard was used to correct for quench.
Calculations.-The radioactivity of each whole organ was determined and expressed as a percentage of the total injected dose. The total radioactivity in the blood was taken to be that in a 1-5 ml volume. Mean values and standard deviations were calculated for all experimental groups.
Autoradiography.-Liver, spleen, small gut and brain were excised 3 days after i.v. or i.p. injection of labelled C. parvum. Tumour was studied 7 and 14 davs after i.v. injection of the vaccine. The tissues were fixed in formol saline and autoradiographs were prepared using the standard stripping-film technique (Pelc, 1956) . Histological sections were stained with haematoxylin and eosin. Table. There was significant reduction (P < 0O001) of metastases in all mice which received C. parvum. But there was no difference in the number of metastases between the different C. parvum groups.
Hepatosplenomegaly.-Groups of 5 mice were injected i.v. with labelled C. parvum and killed 4 h and 1, 3, 7 and 14 days after injection. The whole body, liver, spleen and thymus were weighed at each interval after injection (Fig. 2. ). There was an increase in the weight of the liver and spleen, and a decrease in that of the thymus. There was a slight drop in body weight, which had returned to normal by 14 days after C. parvum. the injected dose was present at 4 h and this value thereafter decreased. Highest )ur when injected either i.v. or i.p. at activity was found in the liver: 4 h after game time as tumour into groups of 8 injection the liver contained 59% of the C. parvum caused a significant injected dose, by 1 and 3 days it was 36% )ition of tumour growth when com-and at 7 days it had fallen to 20%. By I with that in control mice given 14 days only 10% was detected. e (on Day 21. P = 0 001). There was Moderate amounts of radioactive label were recorded in the spleen (2-5% at 4 h, 3% at 1 day and 1-15% at later times) and the small gut (1 5 0o at 4 h, 6 o at 1 day and progressively less thereafter). In the peritoneal fluid and brain, only slight activity was detected, and no consistently significant levels of radioactivity were recovered from the mesenteric lymph nodes, thymus, heart, bone marrow, skin or muscle. Intraperitoneal injection. The distribution of radioactivity after i.p. injection of labelled C. parvum is shown in Fig. 4 . Activity was rapidly cleared from the peritoneal cavity. At 4 h after injection only 8 % of the injected dose was recorded.
Distribution of C. parvum in normal mice
This value had decreased to 400 at 1 day, and there was a further reduction to 300 at 3 days and to 10/ at 7 days. Highest activity was found in the liver. At 4 h, 26% was detected. This value gradually decreased, until only 400 was present at 14 days. Moderate amounts of radioactive label were recovered from the spleen (400 at 4 h, thereafter decreasing) and the small gut (2.5% at 4 h, gradually increasing to a maximum of 5% at 3 days). A moderate count (3 50o) was recorded in the lungs at 4 h, but little was found at later times. Only slight activity was found in the brain and blood, and no consistently significant activity was recovered from the mesenteric lymph nodes, thymus, heart, bone marrow, skin or muscle.
Subcutaneous injection. The distribution of activity after sec. injection of radiolabelled C. parvurn is shown in Fig. 5 (Fig. 6b) . 2.9% of the injected dose was detected at 1 day, when tumour weighed 453 mg. By 14 days the activity recovered had risen to 5.6% and tumour weight to 1714 mg. 0.1% of the injected dose was recorded in the lymph nodes draining these tumours.
Autoradiography
Autoradiographs were prepared from liver, spleen, small gut and brain taken from mice 3 days after i.v. or i.p. injection of labelled C. parvum. Tumour was studied either 14 days after i.v. injection of C. parvum from mice given the vaccine at the same time as tumour inoculation, or 7 days after injection when the vaccine was given 7 days after tumour.
Liver.-The liver was heavily labelled (Fig. 7) . Grains were observed in the cytoplasm of Kuppfer cells and in histiocytes around the periphery of granulomas. granuloma formation in the liver (Castro, 1974b; Mosedale and Smith, 1975) .) Spleen.-Grains were observed in the phagocytic cells of the spleen (Fig. 8 ). These were mainly present in the red pulp, in the sinus lining cells and the chords. A few labelled cells were found in the white pulp near the marginal sinus.
Small gut.-Only 2 labelled cells were found in the small gut sections and both of these were phagocytic. One was observed in the lamina propria and the other in the gut lumen. No label was found in gut epithelium or crypts of Lieberkiihn.
Brain.-There were no labelled cells in the sections of brain which were examined.
Tumour.-Many dividing tumour cells were seen. No labelled cells were observed in the sections which were examined.
DISCUSSION
An ideal radioactive marker for the determination of the location of C. parvum after injection would be labelled cell wall or inner wall membrane, since it is these constituents which stimulate the reticuloendothelial system (Adlam, Reid & Torkington, 1975) . However, the available nutrients for the incorporation of radiolabel into these sites are the 14C_ or 3H-labelled sugars and glycerol, and these substances are extensively degraded to CO2 during growth of the bacteria under anaerobic conditions. Another method of labelling the cell wall would be to iodinate a killed bacterial suspension, using Chloramine T and 1251 (Hunter, 1973) . However, we considered that this technique, which substitutes 1251 into the surface tyrosine groups, might alter the bacterial cell wall and consequently change the in vivo distribution of C. parvunm.
We therefore chose to label the DNA within the bacterium as an alternative, since little or no degradation of DNA precursors should occur during anaerobic growth, and no substantial change in cellular structure should result. We obtained highly labelled bacteria with little or no low-mol.-wt. materials in the bacterial suspensions which were used for injection.
The labelled formalin-killed C. parvurn was found to be morphologically similar to an unlabelled vaccine obtained from Burroughs Wellcome, which had been prepared using a similar technique. This labelled C. parvrum was shown to have similar biological properties to the commercial vaccine. Lewis lung carcinoma was used to test the antitumour properties of labelled C. parvum, as we have studied this tumour system in detail Castro, 1975, 1976a) . There were no differences in the antitumour or antimetastatic effects of the labelled C. parvum and unlabelled commercial C. parvum. J.v. injection of labelled C. parvum caused an increase in liver and spleen weight and a decrease in that of the thymus. Similar weight changes after injection of commercial C. parvum have been reported elsewhere (Halpern et al., 1963; Castro, 1974b) and these particular weights were not significantly different from those found previously in this laboratory, using unlabelled C. parvum in the same strain of mouse (Sadler and Castro, 1976a) .
The labelled C. parvum was injected i.v., i.p., or s.c. into normal mice and its localization up to 14 days after injection determined. The distribution of activity after i.v. or i.p. injection was similar, in that highest counts were found in the liver and moderate activity was recovered from the spleen, lungs and small gut. After both routes of injection, activity was rapidly cleared from the site of injection. The localization of activity after s.c. injection was quite different, for the majority of counts were found at the site of injection and little was recovered in other tissues. This difference in localization is probably the reason why i.v.-or i.p.-injected C. parvum causes hepatosplenomegaly and inhibits tumour growth to a greater extent than s.c.-injected vaccine (Sadler and Castro, 1976a) .
This varied distribution of C. parvum after different routes of injection might be important in the clinical treatment of localized tumour or metastases. In recent studies (Likhite and Halpern, 1974; Scott, 1974b; Woodruff and Dunbar, 1975) C. parvum-enhanced specific anti-tumour immunity has been shown after injection of the vaccine directly into tumour, suggesting that contact of C. parvum and tumour may be an advantage in treatment. Subcutaneous (or intra-tumour) injection of C. parvum might be used against skin tumours, i.v. injection against liver or lung tumours and i.p. injection against ascitic tumours. In our own studies, using the Lewis lung carcinoma, we found i.v. or i.p. C. parvum equally effective in inhibiting pulmonary metastases (Sadler and Castro, 1975) .
The role of immunotherapy in the treatment of brain tumours is not clear. Our observation that only low levels of activity were present in brains after injection of labelled C. parvum correlates well with the finding that C. parvum has only slight inhibitory effects on the growth and induction of experimental intracerebral tumours (Osborn, Sadler and Castro, 1977) . This result was not unexpected, as the blood-brain barrier allows only a poor immunological response to antigen within the brain (Holman, 1972; Medawar, 1948; Denlinger et at., 1975) .
After all routes of injection, there was a loss of activity, so that by 14 days after injection of labelled C. parvum, only 5-10% of the injected dose could be recovered from the tissues sampled. This radioactive label was excreted in both the urine and faeces. No investigations were made to determine whether this activity was in the form of labelled C. parvum or as free [3H] thymidine.
The distribution of labelled C. parvum in mice bearing Lewis tumour was found to be similar to that in normal mice. Activity was recovered from tumour, but there was no direct relationship between the effectiveness of the vaccine in inhibiting tumour growth and the counts recorded in the tumour. Indeed when C. parvum was administered at the same time as tumour inoculation, the higher levels of activity were detected in the larger tumours which grew in the s.c.-treated mice. However, highest radioactive counts were recovered from tumour when C. parvum was given i.v. 7 days after tumour. C. parvum administered at this time, when the tumour is fully vascularized and about 1 cm in diameter, has been shown to be effective in inhibiting tumour growth (Sadler and Castro, 1976a) .
Autoradiographs were prepared from small gut, brain, tumour, liver and spleen. Radioactive label was found only in the cytoplasm of phagocytic cells. Cells with label over the nucleus were sought, but not found, in the epithelium and crypts of Lieberkuhn of the small gut, and in tumour, where cell division occurs rapidly, The absence of radioactivity in nuclear DNA is indicative that very little or no [3H] thymidine was lost from the bacteria after injection. Indeed, it seems unlikely that the thymidine would be lost, as evidence from other bacterial systems suggest that, even after enzymatic and detergent disruption, detachment of DNA from cell wall or inner wall membranes can only be achieved by considerable mechanical disruption (Fielding and Fox, 1970) .
In the small gut, only 2 labelled cells were detected and both of these were macrophages. One was observed in the lamina propria and the other in the gut lumen. Up to 3 days after injection of labelled C. parvum, there was a gradual increase in activity recovered in the small gut, whereas in other tissues, except tumour, there was a loss of activity. There is some evidence for the migration of Kupffer cells to the, lungs (VernonRoberts, 1972) , and it is possible (though not proven by the observation of only 2 cells) that macrophages migrate from the liver or some other tissue to the lamina propria of the small gut and into the gut lumen. Indeed, moderate counts were recorded in the gut contents.
In the brain, no labelled cells were observed in the sections studied. The activity recovered after injection of labelled C. parvum was relatively low, and therefore very few labelled cells must have been present. Similarly, no labelled cells were found in tumour.
Labelled phagocytic cells were most numerous in the liver and spleen. After all routes of injection, C. parvum was rapidly cleared from the blood, and it is probable that these macrophages were responsible for the clearance.
The antitumour action of 0. parvum is thought to be mediated by activated macrophages (Scott, 1974c; Ghaffar, Cullen and Woodruff, 1975) . The uptake of this vaccine by these cells may be important in the initiation of the response. At present, it is unclear whether T cells are also required for the anti-tumour action of C. parvum (Woodruff, Dunbar and Ghaffar 1973; Christie and Bomford, 1975; Sadler and Castro, 1976b) .
We therefore conclude that in vitro labelling of living C. parvum with [3H] thymidine, followed by formalin killing, is a satisfactory technique for producing a radiolabelled killed C. parvum which retains the same btological properties as unlabelled killed C. parvum. Our determination of the tissue localization of C. parvum after various routes of injection could be of use in the elucidation of the mechanism of action of this vaccine and in the drafting of protocols for clinical trials.
